期刊文献+

自身抗体阴性类风湿关节炎的临床及实验室特点 被引量:23

Clinical and laboratory features of rheumatoid arthritis that has negative serum autoantibodies
原文传递
导出
摘要 目的探讨自身抗体阴性类风湿关节炎(rheumatoid arthritis,RA)的临床及实验室特点。方法分析247例RA患者,比较自身抗体阴性RA(30例)与抗体阳性RA的临床及实验室特点,以骨关节炎患者(34例)作为对照组。结果自身抗体阴性的RA占12.1%(30/247),自身抗体阴性RA患者的晨僵时间较自身抗体阳性RA患者短(P<0.05);血清免疫球蛋白IgG、IgA及γ球蛋白比率水平显著低于自身抗体阳性RA患者(P<0.01)。而自身抗体阴性RA患者的红细胞沉降率(ESR)、C反应蛋白(CRP)、免疫球蛋白IgM、γ球蛋白比率均明显高于骨关节炎患者(P<0.05),同时与骨关节炎患者比较,其血红蛋白降低及血小板升高的幅度更明显(P<0.05)。结论RA患者中自身抗体阴性者占12.1%,提示自身抗体阴性RA并不少见。ESR、CRP、免疫球蛋白IgM及γ球蛋白的增高在自身抗体阴性RA的诊断中有参考意义。 Objective To investigate the clinical and laboratory features of auto antibody-negative rheumatoid arthritis (RA). Method The clinical features and laboratory parameters were compared between auto-antibody-negative (n=30) and-positive (n=217) RA patients. The patients with osteoarthritis (OA, n=34) were used as controls. Results Thirty (12.1%) of 247 RA patients were auto-antibody-negative. It was shown that morning stiffness of the joints in auto-antibody-negative RA was shorter than that of auto-antibody-posi- tive RA patients (P〈0.05). The levels of IgG, IgA and gamma hemoglobin in auto-antibody-negative RA patients were significantly lower than those in patients with positive antibodies (P〈0.01). However, as compared with OA patients, auto-antibody-negative RA individuals had higher levels of ESR, CRP, IgM and gamma hemoglobin (P〈0.05). Conclusions More than 10% RA patients are auto-antibody-negative. ESR, CRP, IgM and gamma hemoglobin are valuable parameters in the diagnosis of auto-antibody-negative RA patients.
出处 《中华风湿病学杂志》 CAS CSCD 2007年第8期466-468,共3页 Chinese Journal of Rheumatology
关键词 关节炎 类风湿 自身抗体 骨关节炎 Arthritis, rheumatoid Auto-antibodies Osteoarthritis
  • 相关文献

参考文献10

  • 1Vencovsky J, Machacek S, Sedova L, et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann rheum Dis. 2003, 62: 427-430.
  • 2穆荣,孙晓云,栗占国.类风湿因子和抗环瓜氨酸多肽抗体联合检测在类风湿关节炎诊断中的意义[J].北京大学学报(医学版),2005,37(5):498-500. 被引量:31
  • 3Clegg DO, Ward JR. Diagnostic criteria in rheumatoid arthritis. Scand J Rheumatol, 1987, 65 Suppl: S3-11.
  • 4Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis, 2006, 65: 845-851.
  • 5Ceccato F, Roverano S, Barrionuevo A, et al. The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Clin Rheumatol, 2006, 25: 854-857.
  • 6Agrawal S, Misra R, Aggarwal A. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA. Clin Rheumatol, 2007, 26: 201-204.
  • 7Korkmaz C, Us T, Kasifoglu T, et al. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations. Clin Biochem, 2006, 39: 961-965.
  • 8Shin YS, Choi JH, Nahm DH, et al. Rheumatoid factor is a marker of disease severity in Korean rheumatoid arthritis. Yonsei Medical J, 2005, 46: 464-470.
  • 9Papadopoulos IA, Katsimbri P, Katsaraki A, et al. Clinical course and outcome of early rheumatoid arthritis. Rheumatol Int, 2001, 20: 205-210.
  • 10Aho K, Heliovaara M, Knet P, et al. Serum immunoglobulins and the risk of rheumatoid arthritis. Ann Rheum Dis, 1997, 56:351-356.

二级参考文献11

  • 1何菁 贾汝琳 等.隐性类风湿因子在类风湿关节炎诊断中的意义[J].中华风湿病杂志,2001,5:24-24.
  • 2Vincent C, Simon M, Sebbag M, et al. Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis [J]. J Rheumatol,1998,25:838-846
  • 3van Jaarsveld CH, ter Borg EJ, Jacobs JW, et al. The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis[J]. Clin Exp Rheumatol, 1999,17:689-697
  • 4Suzuki K, Sawada T, Murakami A, et al. High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis[J]. Scand J Rheumatol,2003,32:197-204
  • 5Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatiod arthritis[J]. Arthritis Rheum, 1988, 31: 315-324
  • 6Saraux A, Berthelot JM, Devauchelle V, et al. Value of antibodies to citrulline-containing peptides for diagnosing early rheumatoid arthritis[J]. J Rheumatol, 2003,30: 2535-2539
  • 7Aho K, Palusuo T, Kurki P. Marker antibodies of rheumatoid arthritis: diagnostic and pathogenetic implications[J]. Semin Arthritis Rheum,1994,23:379-387
  • 8Goldbach-Mansky R, Lee J, McCoy A, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset[J]. Arthritis Res,2000, 2: 236-243
  • 9Zeng X, Ai M, Tian X, et al. Diagnostic value of anti-cyclic citrullinated peptide antibody in patients with rheumatoid arthritis[J]. J Rheumatol, 2003,30:1451-1455
  • 10Forslin K, Vincent C, Serre G, et al. Antifilaggrin antibodies in early rheumatoid arthritis may predict radiological progression[J]. Scand J Rheumatol, 2001,30:221-224

共引文献30

同被引文献191

引证文献23

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部